Related Experiment Video

Updated: Jun 2, 2026

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the

Rachel Cavill1, Atanas Kamburov, James K Ellis

  • 1Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Plos Computational Biology
|April 13, 2011
PubMed

Insights

Integrating transcriptomic and metabolomic data reveals consensus pathways linked to platinum drug sensitivity in tumors. This approach enhances biomarker discovery for predicting chemotherapy response.

Area of Science:

  • Biochemistry
  • Genomics
  • Pharmacology

Background:

  • Tumor cell chemosensitivity to platinum-based drugs is crucial for treatment efficacy.
  • Understanding the molecular basis of drug response is key for personalized medicine.

Purpose of the Study:

  • To integrate transcriptomic and metabolomic data for identifying consensus biochemical pathways associated with platinum drug sensitivity.
  • To explore the role of metabolic pathways in predicting response to platinum chemotherapy.

Main Methods:

  • Utilized transcriptomic and metabolomic measurements from the NCI60 cell line panel.
  • Developed a novel approach for direct integration of molecular profile data at the pathway analysis level.
  • Validated metabolic pathway associations across a panel of chemotherapeutics.

Main Results:

  • Direct integration of metabolome and transcriptome data improved consensus pathway detection by 76%.
  • Identified associations between platinum sensitivity and metabolic pathways including the TCA cycle, pyruvate metabolism, lipoprotein uptake, and nucleotide synthesis.
  • Confirmed the specificity of metabolic pathway associations to platinum sensitivity.

Conclusions:

  • Metabolic phenotyping can aid in predicting patient response to platinum chemotherapy.
  • Consensus-phenotype integration of molecular profiling data is a powerful tool for biomarker discovery and understanding drug response mechanisms.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...